DS recapitulates several risk factors associated with brain insulin resistance development, i.e., increased Aβ production and deposition due to triplication of the amyloid precursor protein gene APP mapping to human chromosome 21 (HSA21), and increased rates of obesity, glucose intolerance, and T2DM. The gene discussed is APP; the disease is obesity disorder.